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Abstract 
 
Subjects routinely control the vigor with which they emit motoric responses. However the 
bulk of formal treatments of decision-making ignores this dimension of choice. A recent 
theoretical study suggested that action vigor should be influenced by experienced average 
reward rate, and that this rate is encoded by tonic dopamine in the brain. We previously 
examined how average reward rate modulates vigor as exemplified by response times, and 
found a measure of agreement with the first suggestion.  In the current study we examined 
the second suggestion, namely the potential influence of dopamine signaling on vigor. 
Ninety healthy subjects participated in a double-blind experiment in which they received 
one of the following: placebo, L-DOPA (which increases dopamine levels in the brain) or 
citalopram (which affects brain serotonin levels). Subjects performed multiple trials of a 
rewarded odd-ball discrimination task in which we varied the potential reward over time in 
order to exercise the putative link between vigor and average reward rate. As before, we 
found a significant fraction of the variance in subjects' responses could be explained by our 
experimentally manipulated changes in average reward rate. Crucially, this relationship was 
significantly stronger under L-Dopa than under Placebo, suggesting the impact of average 
reward levels on action vigor is indeed subject to a dopaminergic influence.  
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INTRODUCTION 
 
Whenever subjects perform actions, they face two fundamental classes of choice. One 
concerns which of a number of available actions to perform. The empirical literature in 
psychology and neuroscience on this topic has been the subject of powerful and illuminating 
theoretical treatments, based on normative decision-theoretic principles. The other class of 
choice concerns when, or how vigorously, one should perform an action. This is actually of 
broader significance because in many paradigms in animal learning, such as free operant 
tasks, vigor is the only dependent variable. Much is known about how subjects behave in 
such tasks but there has been little theoretical work examining and explaining these data. 
 
One line of theoretical investigation has considered instrumental aspects of vigor in free-
operant tasks (Niv et al, 2007). This account starts with two key assumptions: the first is that 
subjects seek to maximize the average rate of net utility per unit time; the second is that 
utility is decreased according to the cost of performing an action, and that performing an 
action more quickly (i.e., more vigorously) is more costly. Given a hyperbolic functional form 
for this increasing cost, vigor turns out to be determined by the opportunity cost of being 
slothful, where this opportunity cost is just the average rate of net utility.  
 
In a recent study (Guitart-Masip et al, 2011) we tested this prediction in a qualitative 
manner by modulating the monetary rewards subjects could receive for making appropriate 
responses. We showed that subjects indeed modulated their response times based on the 
local average reward rate, i.e. the average amount of reward they had received over the last 
few minutes in the task. On the other hand, we found that the size of the instantaneously 
available reward for the immediate choice had less of an effect, with larger offers being, if 
anything, antagonistic to fast performance. Although this finding is perhaps surprising given 
the, coarser scale, Pavlovian effects on vigor examined in paradigms such as the monetary 
incentive delay task (Knutson et al, 2000), it is in keeping with the actual model that inspired 
the experiment (Niv et al, 2007). 
 
Based on various sources of evidence (Evenden and Robbins, 1983; Floresco et al, 2003; 
Grace, 1991; Salamone and Correa, 2002), it was also predicted that the opportunity cost of 
time, i.e., the average rate of net appetitive utility, would be conveyed by tonic levels of the 
neuromodulator dopamine (Niv et al, 2007). This idea is supported by a large literature 
showing that dopamine manipulations have specific effects on the vigor of motivated 
behavior (Aberman and Salamone, 1999; Correa et al, 2002; Mingote et al, 2005; Salamone 
et al, 2001; Sokolowski et al, 1998). For example, dopamine depletion in rat nucleus 
accumbens leads to less responding in a reward schedule requiring a large number of lever 
presses, but not for a small number of lever presses (Aberman and Salamone, 1999). Indeed, 
the latter experimental data was a key influence on the computational model of (Niv et al, 
2007) Other experiments have shown that dopamine depletion reverses animals’ preference 
from a high-cost/high-reward to a low-cost/low-reward option in multiple experimental 
settings  (e.g. (Salamone et al, 1991; Sokolowski and Salamone, 1994); for a recent review on 
these issues see (Salamone and Correa, 2012)). 
 
A more speculative possibility is that tonic levels of another neuromodulator, namely 
serotonin, could be involved in reporting the average rate of net aversive utility, and, by 
symmetry, be involved in behavioral sloth.  The reason for this is the (still somewhat 
contentious) notions of opponency between dopamine and serotonin (Boureau and Dayan, 
2011; Cools et al, 2011; Daw et al, 2002; Deakin and Graeff, 1991), and indeed serotonin’s 
known involvement in behavioral inhibition (Boureau and Dayan, 2011; Cools et al, 2011; 
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Crockett et al, 2009; Huys and Dayan, 2009; Soubrié, 1986). This leads to a possibility that 
boosting serotonin levels might have opposite effects on vigor to that seen when boosting 
dopamine levels. Here, we set out to test the effect on vigor of manipulating dopamine and 
serotonin in healthy human subjects.   
 
Participants were assigned to receive placebo, levodopa (150mg), or citalopram (24mg in 
oral drops, equivalent to 30mg in tablets) and performed the exact task described in our 
previous paper (Guitart-Masip et al, 2011). The pharmacological agents are assumed to 
increase postsynaptic levels of dopamine and serotonin, respectively.  We predicted that an 
increase in dopamine after levodopa administration would lead to a stronger modulation of 
the response times due to the influence of average reward rate. An additional possibility 
would be that an increase in serotonin after citalopram would weaken this modulation. 
 
METHODS 
 
Subjects  
 
90 healthy volunteers were recruited for our pharmacological experiment (pharmacological 
subjects) using the subject pool associated with University College London’s Psychology 
Department. A further 25 healthy volunteers were recruited for a control experiment (tired 
subjects). They received full written instructions, and provided written consent in 
accordance with the provisions of the University College London Research Ethics Committee.  
 
“Pharmacological” subjects 
 
Participants were randomly assigned to one of three treatment groups: 30 participants 
received levodopa (13 female; age range 17 years; mean 24.07, SD = 4.08 years), 30 
participants received citalopram (17 female; age range 15 years; mean 23.6, SD = 4.2 years), 
and 30 participants received placebo (13 female; age range 11 years; mean 24.23, SD = 3.18 
years). The study was double blind. All participants were right-handed and had normal or 
corrected-to-normal visual acuity. None of the participants reported a history of 
neurological, psychiatric or any other current medical problems.  
“Tired” subjects 
 
The pharmacodynamics of levodopa and citalopram imply that a waiting period is necessary 
before they exert potent effects on dopamine and serotonin. Further, before performing the 
vigor task, subjects participated in an unrelated task that also yielded monetary reward. 
These factors may potentially cause fatigue and a lower interest in the task for the subjects 
participating in the current experiment, and so temper the linkage to results of our previous 
study (Guitart-Masip et al., 2011).  Consequently, to address this we examined the potential 
role of exhaustion and lowered interest by recruiting an additional twenty-five subjects (14 
female; age range 15 years; mean 24.2, SD = 4.3 years) as above, who performed an 
unrelated task (reward based decision-making) for an average of 150 minutes before 
performing the vigor task. We intended their performance to mimic the behavior of the 
subjects in our pharmacological sample, but in the absence of any pharmacological 
manipulation.  
 
Experimental procedure for the drug study 
 
Participants completed the vigor task (see below) 100 minutes after receiving levodopa 
(150mg + 37.5mg benserazide) or 220 minutes after receiving citalopram (24mg in drops 
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which is equivalent to 30 mg in tablet). To ensure participants and researchers were blind to 
condition, on the day of the experiment each participant was allocated to one treatment 
group and received one glass containing either citalopram or placebo. Two hours later they 
received another glass containing either placebo or levodopa, and waited for another hour 
before engaging for 40 minutes in a go/no-go learning task (Guitart-Masip et al, 2012b) 
reported elsewhere. On the go/no-go task participants earned a minimum of £10 and a 
maximum of £35, based on their performance. Therefore, for all treatments groups, 
participants participated in the vigor task 220 minutes after arriving at the laboratory and 
after receiving a substantial monetary incentive. Participants completed a subjective state 
analogue-scales questionnaire on three occasions. We did not detect any difference in 
subjective ratings between treatment groups (see Supplementary Online Material for 
details).  
 
Behavioral Paradigm (vigor task) 
 
The behavioral paradigm was presented using a regular PC monitor and keyboard, exactly as 
described in Guitart-Masip et al. (2011). The layout of a trial is depicted in Figure 1A. In each 
trial subject could receive a potential payout in the range 1-100 pence, as presented visually 
on the screen at the beginning of the trial. The potential payouts, Rt were varied across trials 
according to a pre-specified function of trial number. This function was fixed across subjects 
and designed to vary over time in a way to minimize the correlation between the available 
reward, averaged reward rate and the linear component (see below). The potential payout 
function used is shown in Figure 1B. After a variable period (750–1250 msec, later referred 
to as the Intertrial interval), subjects were shown three visual figures and had to indicate the 
“odd one out” by pressing a button. If subject responded within 500 msec by pressing the 
button corresponding to the deviant stimulus the trial was considered successful. To keep 
participants engaged throughout the task we induced unexpected misses by lowering the 
time constraint to 400 msec in 20% of the trials. Subjects were informed as to their success 
on the trial after being shown a blank screen for 500 msec. Feedback was followed by 
another blank screen and the beginning of the next trial. 
 
Subjects performed 458 to 472 trials within the 27 minutes time limit allocated. For subject 
payments 10% of the trials were chosen randomly, and subjects were paid the sum of the 
value of the successful subset of those trials, plus a fixed fee of £5 that was added to the 
amount of money that they had obtained on the previous, unrelated, task (see experimental 
procedure). Critically, this incentive structure implies that the faster they make correct 
responses, the more money they could potentially make. 
 
Table 1 shows the average (and standard deviation) money made by each group on the vigor 
task. Four subjects amongst the ‘pharmacology’ participants, and one from the ‘tired’ 
participants, managed fewer than 200 correct trials within the available experimental time 
limits and were thus discarded from further analysis.  
 
 
Data Analysis 
 
We fitted a log normal distribution to each individual’s reaction times (RTs) and removed 
any data points that were more than three standard deviations from the individual mean. 
We then recalculated the mean and standard deviations, and repeated this procedure. 
Missed trials (trials without any behavioral response) were not included in the analysis. To 
allow subjects to get used to the task we only analyzed trials 21 to 460. Participants who 
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managed fewer than 200 complete trials (correct button press within the time limit) were 
subsequently omitted from further analysis. 
 
<Insert Figure 1 around here> 
 
Given the log-normalized data, we assumed a linear model for the contribution of different 
factors on the z-scored response times for each subject i.  
logܴܶሬሬሬሬሬԦ௜ ൌ ധܺ௜ כ  ߚԦ௜ ൅ ߝԦ௜  
 
where the columns in the ധܺ matrix were given by the following variables which were chosen 
in the light of the results of our previous study (Guitart-Masip et al, 2011): 
Rt: available reward for the subjects to win in a given trial. 
: average reward signal, as given by , where  is the reward achieved 
in the previous trial. This update rule is equivalent to the Rescorla-Wagner rule, which is 
used routinely in learning approaches to average reward reinforcement learning. The update 
or learning rate for the average reward α was a free parameter of a random effects model 
fitted to each subject’s responses according to the algorithm described below. The update 
rate could range between 0 (equivalent to no learning) and 1 (equivalent to only using the 
reward in the previous trial).  
 
Repetition of stimulus (RS): binary vector indicating whether the stimulus in the last trial was 
the same as in this trial.  
 
Linear: linear function. 
 
Too late: binary return indicating whether the response was too late in the previous trial. 
 
Intertrial interval (ITI): pretrial interval while waiting for the stimulus to be presented.  
 
Our key variables of interest were the available reward, Rt and the average reward signal .  
 
The model is similar to a linear model for linear regression, apart from the effect of the 
individualized learning rates α. We treated it as a random effects model with a top level, 
Gaussian, prior 
 
for the β parameters and the learning rates α (with the 
latter being transformed through a sigmoid to restrict their range to the interval  [0,1] so 
they can be treated uniformly). We fit the values of ߤ୮୰୧୭୰ and ߑ୮୰୧୭୰ using a Bayesian 
Expectation-Maximization method, using regular linear regression as the inner loop for 
maximizing the likelihood with respect to β. We made a Laplace approximation about this 
maximum to realize an approximately normally distributed (but unnormalized) likelihood 
proportional to  , which was multiplied by 
 
and normalized to 
create the posterior estimate of each β value  . This can be easily done 
analytically as 
 
and 
. 
 
In the M-step the parameters for the prior were optimized as 
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where the dimensionality k=7 and m is the number of subjects.  
 
There is an analytical solution to this maximization with  and 
. 
 
The E and M steps were repeated until the change in estimated variables between two E-
steps were less than 0.001, signifying convergence. 
 
Notice that our approach was not fully Bayesian in that we did not assume a ‘hyper-prior’ 
over the parameters for the prior. Having estimated the β-values, we then asked whether 
any of them explained a significant amount of variability of the data. 
 
 
Re-analysis of original data 
 
In our previous study (Guitart-Masip et al, 2011), we used the same experimental method, 
but no pharmacological treatment and also no waiting or intermediate task (the go/no-go 
task mentioned above). We had also employed a simpler analysis method. In order to 
compare our current results with the earlier ones, we reanalyzed the results of that prior 
experiment using the statistical methods described above.  Out of the thirty-nine subjects 
we excluded one subject due to failure of the recording software. 
 
 
 
RESULTS 
 
We tested the effects of manipulating dopamine (using levodopa) on the vigor displayed by 
human subjects using a task developed to test how reward modulates reaction times. This 
task was the same as in our previous published study (Guitart-Masip et al, 2011), requiring 
speeded responses in an ‘odd-one-out’ task, where subjects were rewarded for being both 
accurate and suitably fast (see Methods).  
 
For completeness, we report results and comparisons among three different sets of data. 
Set Dorig comes from reanalyzing data from (Guitart-Masip et al, 2011) using a more 
sophisticated statistical method (a random effects model) that we adopted for our new 
data, in view of an anticipated need to make comparisons between different groups of 
subjects.  
 
Dataset Dpharm was the main experimental focus in the present paper. Subjects were 
administered placebo, levodopa or citalopram and after a fixed time period (which included 
participation in an unrelated reward task) performed the vigor task. Dpharm comprises data 
from the three groups Dplac, Dldopa, Dcit. 
 
Finally, we collected an additional dataset Dtired to assess the effect of the key experimental 
difference between the paradigm underlying Dorig and Dpharm, namely the requirement for 
μ
priorNew
=
1
m
μposti
i

ΣpriorNew =
1
m
(μ
post
i )2 − (μ
priorNew
)2( ) + Σposti
i

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participants to remain on our premises for 220 minutes and engage in a learning task before 
performing the vigor task. This waiting period may have caused fatigue and decreased 
motivation in participants. To assess the effect of the waiting period, if any, we tested 
twenty-five subjects using a similar design: in effect these subjects participated in the vigor 
task 150 minutes after arrival for the study and after engaging in an unrelated reward based 
decision-making task with a pay-off ranging between £5 and £20.  
 
Table 1 shows for each data set the means (and standard deviations) of the number of 
performed trials, the number of correct responses within the trial time limit, the number of 
trials with too late responses, and the number of wrong button presses. There was no 
significant difference across groups on any of these measures (Wilcoxon signed-rank test, 
p>0.05). Table 1 also includes the amount of money won and the average response times for 
each experiment, which also did not differ significantly across groups (1 way ANOVA, 
F(147)=0.62, p>0.05 and F(147)=1.08, p>0.05 respectively). 
 
To examine the factors influencing the subjects’ reaction times, we used an Expectation 
Maximization (EM) variant of linear regression (see Methods). The regressors of interest 
were the available reward and the average reward history (vigor signal), and several 
nuisance variables (see Methods).  
 
The most significant formal difference to our previous analysis was that here, we fit the 
learning rate ߙ used to calculate the average reward on a subject-by-subject basis as part of 
the random effects model, rather than using a single value for ߙ across subjects estimated 
based on a maximum likelihood fit to pilot data (Guitart-Masip et al, 2011). Learning rates 
were individually fit in order to rule out the possibility that any effects of the 
pharmacological treatments on vigor were caused by undetected differences in learning 
rates. Our results, however, showed no difference in learning rate across data sets  (1-way 
ANOVA F(147)=1.38, p>0.05) nor across the three pharmacological groups (F(85)=2.09, 
p>0.05)) .  
 
<Insert Figure 2 around here>  
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 Original Tired Placebo L-Dopa Citalopram 
# performed trials 459.9(3.0) 465.9 (3.1) 466.3 (2.4)
 
465.6 (2.2) 466.2 (2.4)
# correct trials 339.5 (49.2) 351.0 (58.6) 355.9
(46.0) 
345.1(47.1) 347.6 (44.8)
# too late trials 86.8 (40.2) 
 
86.8(45.1) 78.8(37.0)   86.7(40.2) 82.3 (39.9)
# wrong trials 32.9 (25.0) 28.1 (20.4) 31.6(19.7)     33.8(20.4) 36.4(18.5)
Money made £7.17(1.39) £7.21 (1.64) £7.44 (1.29) £6.82 (1.63) £7.09 (1.78) 
Mean Indiv. RT, all 
trials 
415.0 (24.5) ms 408.7 (29.7) ms 403.9(22.9) ms   410.0(23.5) ms 404.9(23.4) ms 
Mean Indiv. RT, 
correct trials 
402.1 (18.8) ms 395.3(21.5) ms 393.1(17.2) ms   398.2(16.3) ms    392.3(15.9) ms 
 
Mean Indiv. RT, too 
late trials 
468.2 (25.4) ms 
 
471.6(29.8) ms 466.9 (20.8) ms 468.0 (24.5) ms   473.0(22.1) ms 
Mean Indiv. RT, 
wrong trials 
365.6 (47.5) ms 360.1(43.6) ms 349.9 (30.2) ms 368.8 (24.7) ms 351.7 (29.8) ms 
Alpha, learning rate 
per trial 
0.1133 (0.1176) 0.1190 (0.0810) 0.1458 (0.1505) 0.1543 (0.1453) 0.0870 (0.0942) 
Table 1: Comparing behavioral responses across all 5 data sets, mean and standard deviations in parenthesis.  
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‘Original’ experiment 
The blue values in Figure 2 show the mean ߚ weights (with associated standard errors) for 
the six regressors for dataset Dorig.  As in the original study, we found that the average 
reward rate (vigor signal) had a significantly negative influence on reaction times (t=-6.91, 
p<0.001); the higher the average reward the quicker the responses. Note that the effect of 
average reward rate is similarly strong in the current analysis despite the fact that the mean 
learning rate across subjects is an order of magnitude higher, and the resulting regressor 
implies the integration of rewards over a much shorter time window (see figure 1b). This 
effect of average reward is very different from the effect of the immediate reward that 
would be available given correct performance on the current trial. Similar to our previous 
analysis we found that immediate reward had no significant impact on the reaction time; the 
ߚ parameter for the available reward regressor was not significantly positive (one sample t-
test, t=1.82, p>0.05). For the nuisance regressors we found a significant negative effect of 
the Repetition of Stimulus, Linear, and Intertrial Interval regressors (t=[-8.72,-9.23,-2.98,-
7.58], p<0.01) in keeping with our previous report. 
 
 
<Insert Figure 3 around here> 
 
‘Tired’ experiment 
We expected that after waiting for 150 minutes and participating in an unrelated reward-
based decision-making task, the impact of average reward on vigor would be reduced, due 
to either fatigue or devaluation of reward. Indeed, although we found that the value of ߚ 
associated with the average reward signal in Dtired was significantly negative (1 sample t-test, 
p<0.05, t=-2.21; red points in Fig 2), the value was significantly less than in Dorig (2-sample t-
test, p<0.05, t=2.58). Effects of other regressors were similar in the two data sets, with only 
Repetition of Stimulus having a significantly stronger effect (2-sample t-test, t=-2.50, p<0.05).  
These results led us to expect a weaker vigor signal across subject groups in Dpharm.  
 
Effects of pharmacological manipulations  
 
Having examined the effect of fatigue we turn to Dpharm, with the results for placebo (Dplac, 
blue), L-Dopa (Dldopa, red) and citalopram (Dcit, green) shown in Fig 3. We first checked the 
effects on the Dplac. For the average reward signal, , we again found a negative weight 
implying that the average reward signal causes subjects to speed up, although this was now 
only borderline significant (t=-1.96, p~=0.06) for the control group. This is in contrast to Dorig, 
but consistent with Dtired. For the available reward, Rt, we found a small positive effect (not 
significant using a t-test, p>0.05, t=0.92), similar to our previous study. As in our previous 
data sets, this implies that there was a weak tendency for subjects to slow down as the 
instantaneously available reward increased. Regarding the nuisance parameters, the 
ߚ coefficients of the Dplac were nearly identical to Dorig , exhibiting no significant difference 
(2-sample t-test, p>0.05 for all regressors, t=[0.69,-1.02, 1.38,-0.26]). 
 
 
<Insert Figure 4 around here> 
 
 
Comparing ‘Placebo’ with ‘L-Dopa’ subjects 
Our main interest in this study was to compare Dldopa with Dplac. As predicted by our 
hypothesis, and the original model (Niv et al, 2007), we found the L-Dopa group had a 
rt
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significantly stronger (more negative) effect of average reward rate compared to  the 
control group (t=-2.28, p<0.05). That is, subjects receiving L-Dopa modulated their response 
times more strongly based on the recent reward history than control subjects (see Figure 3). 
 
There was also a significant difference between the two groups for the Intertrial Interval 
regressor, for which L-Dopa subjects showed less effect of a long preparation time (2 sample 
t-test, p<0.05, t=-2.17). We did not find any other significant difference for the available 
reward regressor, Rt (2-sample t-test, t=-1.86, p>0.05), the linear regressor (t=-1.10,p>0.05), 
or the binary regressors indicating the repetition of stimulus (t=0.21,p>0.05), or a too late 
response in the previous trial (t=-0.73,p>0.05). 
 
Comparing ‘Placebo’ with ‘Citalopram’ subjects 
There was no significant difference between Dcit and Dplac for any regression coefficient (2 
sample t-test, p>0.05), and, indeed, all ߚ values were very similar (see Fig. 3).  Comparing 
the coefficients for the average reward rate (vigor signal) across all groups, we found that 
the values for Dplac and Dcit and Dtired were all significantly different from that for Dorig (2-
sample t-test, t=[3.25, 2.31, 2.58], p<0.05), while that for Dldopa was not (Dorig  versus Dldopa , 
t=0.94, p>0.05), see Figure 4. 
 
Comparing ‘L-Dopa’ with ‘Citalopram’ subjects 
There was no significant difference between Dldopa and Dcit for the effect of the available 
reward or the average reward rate (2 sample t-test, p>0.05, t=[0.65, -1.37]), nor for the 
Repetition of Stimulus or Linear regressors (2 sample t-test, p>0.05, t=[0.39, -0.79]). The only 
regressors to show a significant effect were the Too Late and Inter-trial Interval (2-sample t-
test, t=[-2.49, 2.08], p<0.05, see Fig. 3). This implies that the Citalopram group was less 
spurred on by being too late than the L-Dopa group, while the L-Dopa group was less able to 
use preparation time to speed up their responses. 
 
 
 
DISCUSSION 
 
The relationship between incentive motivation and response vigor has been examined in a 
number of experimental studies (Cools et al, 2005; Satoh et al, 2003; Wittmann et al, 2005) 
showing that for humans and animals alike instrumental actions are influenced by the 
subjective value of rewards in the environment. From a formal standpoint, at least three 
factors should determine the vigor or latency of a response. First, the task itself could 
demand an appropriately quick response, as indeed was the case in the present task, and as 
studied more systematically in active avoidance paradigms (McCleary, 1961). Second, 
subjects may exhibit a trade-off between speed and accuracy, slowing down in order to 
perform more competently. Third, subjects may be able to minimize the opportunity cost 
associated with rewards that are postponed if actions are slothful. 
 
In the context of our task, the first of these effects, and indeed any Pavlovian counterpart, 
such as preparatory or consummatory appetitive impulsivity associated with the prediction 
or presence of a potential reward (Evenden and Robbins, 1983), or appetitive Pavlovian to 
Instrumental Transfer (Talmi et al, 2008), should depend on the immediately offered reward 
ܴ௧. The same dependence would be expected for a speed-accuracy trade-off. We discuss the 
first and second factors later as the theory we set out to test (Niv et al, 2007) considers the 
influence of the third factor, with the opportunity cost being the average rate of reward. 
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We replicated our previous finding (Guitart-Masip et al, 2011) showing that the local 
average rate of reward influences the vigor of the instrumental responses of healthy human 
volunteers. Here, because of the exigencies of the pharmacokinetics of the drugs used, and 
an intermediate task, our subjects were prone to tiredness. Thus, as any finding that reward 
related vigor was reduced could be subject to alternative interpretations we collected 
additional control data to assess the effects of tiredness itself. 
 
Our main finding was that the effect of this fatigue was reversed by the administration of 
levodopa – that is, boosting dopamine boosted reward-related vigor. This effect was specific 
to reward related vigor and not a general effect on arousal as shown by the lack of effect on 
the subjective analogue scale ratings. Moreover, among all the nuisance variables included 
in our regression analysis the only significant difference between placebo and L-Dopa was 
observed on the inter-trial interval regressor, whereby L-Dopa decreased the effect of longer 
preparation times between the display of the available reward and the appearance of the 
target stimulus. If anything this suggests that participants were less aroused after receiving 
the drug. These results confirm a theoretical suggestion that dopamine plays a critical role in 
response vigor (Guitart-Masip et al, 2011), an hypothesis based on a wealth of experimental 
data showing enhanced dopamine levels increase movement vigor in both animals (Lex and 
Hauber, 2008; Salamone and Correa, 2002; Taylor and Robbins, 1986; Ungerstedt, 1971) and 
humans (Guitart-Masip et al, 2012a), and had previously been tested less directly (Mazzoni 
et al, 2007; Salamone and Correa, 2002). These studies implicate the nucleus accumbens as 
at least one relevant site for the invigorating action of dopamine (Balleine, 2005; Lex and 
Hauber, 2008; Parkinson et al, 2002).  
 
According to the original theory, the coupling of dopamine to vigor is instrumental in nature 
(maximizing the average rate of reward) and depends on tonic levels of this 
neuromodulator. However, Pavlovian effects may also play a key part, e.g., a direct coupling 
between reward rate and vigor even in tasks in which this does not actually increase the 
average reward rate. Such a direct coupling can in extreme cases lead to detrimental 
behavior as described in animals (Breland and Breland, 1961) and humans (Guitart-Masip et 
al, 2012b), where vigorous behavior in the light of immediately available reward in fact can 
lead to less overall reward. In our task an effective decoupling of the Pavlovian and 
instrumental systems could be achieved if the inter-trial interval had been increased to 
compensate for trials in which the subjects responded quickly. This manipulation would 
place Pavlovian and instrumental behavioral tendencies in opposition. It would be 
straightforward to test for this, for instance using a reward scheme based on differential 
reinforcement of low rates of responding (for an example of the use of this technique, see 
(Sokolowski and Salamone, 1994)). Our experiment tested a mild form of this in that it 
violated the conditions of the original theory by making the attainment of reward contingent 
upon a response being executed within a fixed time (either 400 or 500 ms). The fact that it is 
the rate of reward based on historical trials rather than the actual offer on the current trial 
that increases vigor can be seen in such Pavlovian terms. 
 
The role of the instantaneously available reward, Rt, was puzzling. Using our previous 
analysis, as well as the more sensitive analysis in this study, we found that it had no 
significant effect on the reaction time (although, as before, the coefficient was numerically 
positive, i.e., associated if anything with slowing down). This is in stark contrast with the 
clear and repeatable effect of the average reward rate . One issue for the lack of effect of 
the instantaneous reward is the possibility that it arises through interaction with a speed-
accuracy tradeoff (for instance, with a tendency for subjects to speed up because of the 
larger reward being tempered by the fact that this might make them less accurate). 
rt
 13
However, as in our previous experiment, we found no between-subjects correlation 
between the available reward and the proportion of correct responses (calculated across 
subjects, r=0.047, p>0.05). This suggests that our main pharmacological effect is 
independent of such tradeoffs, in agreement with a recent study (Winkel et al, 2012). It is 
notable that Parkinson’s patients, with impairments to dopamine signaling, show normal 
speed-accuracy tradeoffs, and merely a propensity to slower actions (Mazzoni et al, 2007). 
Together with our finding of dopaminergic modulation of reward related vigor, it is tempting 
to suggest that dopamine is selectively involved in a coupling between average reward rates 
and vigor. 
 
Our results are apparently not in agreement with studies using the Monetary Incentive 
Delay task or related tasks (e.g. (Cools et al, 2005; Knutson et al, 2001; Wittmann et al, 
2005)). In these experiments participants must perform fast button presses upon receiving a 
go- signal so as to obtain monetary rewards of different magnitudes. Responses are typically 
faster for trials on which larger rewards are available. However, these tasks involve a 
categorical comparison between different levels of reward magnitude, usually involving 
differences of one order of magnitude and where local fluctuations in average reward are 
likely to be small. Future research with a variant of the MID task involving both categorical 
levels of reward magnitude with systematic manipulations of average reward rate are 
needed to understand the exact relationship of available reward and average reward on 
response vigor. 
 
The computational model by Niv and colleagues (2007) suggested that average reward was 
coded by tonic dopamine signals. However, in this theory, the underlying decision problem is 
stationary, which is not true in our experimental test, and so the exact timescale at which 
the average reward is realized in dopaminergic signaling is not completely clear. A variety of 
ways for measuring dopamine concentrations across various timescales are available, 
including cyclic voltammetry (Gan et al, 2010) or microdialysis (Westerink et al, 1996). 
Indeed, experiments using microdialysis have shown that in the ventral striatum dopamine 
increases in a time scale of minutes when animals perform instrumental responses in free 
operant tasks (Ostlund et al, 2011; Segovia et al, 2011). Interestingly, satiation induced a 
decrease in response vigor which was correlated with the decrease in dopamine efflux in the 
shell of the nucleus accumbens (Ostlund et al 2011). 
 
One important complexity concerns phasic dopamine signals, as tonic and phasic aspects of 
dopamine are directly linked (Grace, 1991) and  both are affected by levodopa (Cools, 2006). 
Reward prediction errors induced by cues, potentially including the indication of the 
immediately available reward, are tightly coupled to the phasic activity of dopamine neurons 
(Schultz et al, 1997) as well as with the extracellular concentration of dopamine (Gan et al, 
2010). Further, reaction times are negatively correlated with phasic activity of dopamine 
neurons (Satoh et al, 2003). Therefore, one would expect a negative effect of the available 
reward on the reaction times. However, opposite to this we found a neutral or positive 
correlation, making it unlikely that these short-term dopaminergic signals are responsible for 
the observed dopaminergic modulation of average reward. 
 
Some evidence about the appropriate timescale comes from the learning rates associated 
with average reward that we found through fitting the model. It is important to note that 
there was no significant difference in learning rates between groups, thus this does not 
appear to be a route by which levodopa could affect vigor. However, whereas in the current 
experiment we found that the learning rate ranged between 0.113 and 0.154 per trial, 
implying a time window for averaging of about 30s, in the previous study we used a single 
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learning rate for all subjects fit on pilot data that was 0.012 per trial, implying averaging over 
5 minutes. Due to limitations in sensitivity of the analysis used in the original study we 
generated a single regressor for the averaged reward, with the learning rate fitted to the 
averaged response times across all subjects.  In the current, more sensitive, analysis we fit 
the learning rate individually to each subject. As shown in table 1, calculating the learning 
rate in this way for subjects in the original study leads to a mean value consistent with all 
the other learning rates that we found in the current data set. We therefore suspect our 
previous procedure underestimated the learning rates. Nevertheless, we show here that the 
critical conclusions about the influence of average reward and immediately offered reward 
remain true. 
 
We did not find any effects of citalopram on the impact of average reward on response 
vigor, nor did we find a significant difference from the levodopa group. One major pillar of 
the current version of the computational proposal that serotonin acts as an opponent to 
dopamine (Boureau and Dayan, 2011; Deakin and Graeff, 1991), is that serotonin is directly 
implicated in behavioral inhibition, behavioral quiescence and waiting (Huys and Dayan, 
2009; Miyazaki et al, 2012) as a contrast to dopamine’s involvement in behavioral activation 
(Cools et al, 2011; Guitart-Masip et al, 2012a). However, it is a possibility that the effects of 
serotonin on response inhibition are only observed when actions are taken in a context that 
includes punishments (Crockett et al, 2009, 2012). Furthermore, the involvement of 
serotonin in inhibition is typically complicated (Cools et al, 2011), and even the regional 
effects on serotonin concentration of single doses of citalopram are controversial (Bari et al, 
2010). As a selective serotonin reuptake inhibitor citalopram’s direct effect is via locally 
increased serotonin availability. However, acute citalopram administration can result in 
decreased total postsynaptic serotonin availability, at least at the cortical level (Selvaraj et 
al, 2012), possibly through a presynaptic inhibitory mechanism (Artigas et al, 1996; Hajós et 
al, 1995). Despite these uncertainties on the effects of citalopram on serotonin levels, the 
inclusion of this drug may highlight selective involvement of the serotonergic system in 
specific cognitive functions. One possibility that can be tested in future experiments is 
whether serotonin is involved in coupling the average rate of punishment into sloth (Dayan, 
2012). More complex predictions have been made about the effect of dopamine and 
serotonin in active avoidance paradigms where appropriately early responses are necessary 
to obviate punishments (Dayan, 2012). 
 
One possible limitation of the current experiment relates to the fact that dopamine 
fluctuates with the menstrual cycle (Czoty et al, 2009; Jacobs and D’Esposito, 2011; 
Ossewaarde et al, 2011). This may result in increased variability of the effects of L-Dopa, and 
may have had a deleterious effect when trying to assess cognitive effects of a 
pharmacological manipulation. Importantly, although increased noise could certainly have 
been problematic in the light of a negative result, the significant effect of L-Dopa that we 
found across what was a mixed sample can be seen as more strongly suggestive of the 
involvement of the dopaminergic system in the regulation of response vigour. 
 
In sum, we show that not only is the vigor of human movement modulated by average 
reward rate but that this signal is likely to be encoded by the dopaminergic system in the 
central nervous system. This adds to our understanding of the motivational aspects of 
dopamine, to complement the vastly more extensive investigations of its role in learning 
about rewards. 
 
CONFLICTS OF INTERST 
 
 15
The authors declare that they have no competing financial interests. 
 
ACKNOWLEDGMENTS 
 
This work was supported by a Wellcome Trust Senior Investigator Award 098362/Z/12/Z to 
RJD, the Gatsby Charitable Foundation (UB; PD), and a FP7 Marie Curie Reintegration grant 
for UB (231115); the study was carried out at The Wellcome Trust Centre for Neuroimaging, 
a facility supported by core funding from Wellcome Trust Grant 091593/Z/10/Z. 
 
 
REFERENCES 
Aberman JE, Salamone JD (1999). Nucleus accumbens dopamine depletions make rats more 
sensitive to high ratio requirements but do not impair primary food reinforcement. 
Neuroscience 92: 545–52. 
Artigas F, Romero L, Montigny C de, Blier P (1996). Acceleration of the effect of selected 
antidepressant drugs in major depression by 5-HT1A antagonists. Trends in 
neurosciences 19: 378–83. 
Balleine B (2005). Neural bases of food-seeking: Affect arousal and reward in 
corticostriatolimbic circuits. Physiology & Behaviour 86: 717–730. 
Bari A, Theobald DE, Caprioli D, Mar AC, Aidoo-Micah A, Dalley JW, et al (2010). Serotonin 
Modulates Sensitivity to Reward and Negative Feedback in a Probabilistic Reversal 
Learning Task in Rats. Neuropsychopharmacology 35: 1290–1301. 
Boureau Y-L, Dayan P (2011). Opponency revisited: competition and cooperation between 
dopamine and serotonin. Neuropsychopharmacology 36: 74–97. 
Breland K, Breland M (1961). The misbehavior of organisms. American Psychologist 16: 681–
84. 
Cools R (2006). Dopaminergic modulation of cognitive function-implications for L-DOPA 
treatment in Parkinson’s disease. Neuroscience and biobehavioral reviews 30: 1–23. 
Cools R, Blackwell A, Clark L, Menzies L, Cox S, Robbins TW (2005). Tryptophan depletion 
disrupts the motivational guidance of goal-directed behavior as a function of trait 
impulsivity. Neuropsychopharmacology: official publication of the American College of 
Neuropsychopharmacology 30: 1362–73. 
Cools R, Nakamura K, Daw ND (2011). Serotonin and dopamine: unifying affective, 
activational, and decision functions. Neuropsychopharmacology: official publication of 
the American College of Neuropsychopharmacology 36: 98–113. 
Correa M, Carlson BB, Wisniecki A, Salamone JD (2002). Nucleus accumbens dopamine and 
work requirements on interval schedules. Behavioural brain research 137: 179–87. 
Crockett MJ, Clark L, Apergis-Schoute AM, Morein-Zamir S, Robbins TW (2012). Serotonin 
Modulates the Effects of Pavlovian Aversive Predictions on Response Vigor. 
Neuropsychopharmacology 37: 2244–2252. 
 16
Crockett MJ, Clark L, Robbins TW (2009). Reconciling the Role of Serotonin in Behavioral 
Inhibition and Aversion: Acute Tryptophan Depletion Abolishes Punishment-Induced 
Inhibition in Humans . The Journal of Neuroscience 29 : 11993–11999. 
Czoty PW, Riddick N V, Gage HD, Sandridge M, Nader SH, Garg S, et al (2009). Effect of 
menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus 
monkeys. Neuropsychopharmacology 34: 548–54. 
Daw ND, Kakade S, Dayan P (2002). Opponent interactions between serotonin and 
dopamine. Neural networks: the official journal of the International Neural Network 
Society 15: 603–16. 
Dayan P (2012). Instrumental vigour in punishment and reward. European Journal of 
Neuroscience 35: 1152–1168. 
Deakin JF, Graeff FG (1991). 5-HT and mechanisms of defence. Journal of 
psychopharmacology (Oxford, England) 5: 305–15. 
Evenden JL, Robbins TW (1983). Dissociable effects of d-amphetamine, chlordiazepoxide and 
alpha-flupenthixol on choice and rate measures of reinforcement in the rat. 
Psychopharmacology 79: 180–6. 
Floresco SB, West AR, Ash B, Moore H, Grace AA (2003). Afferent modulation of dopamine 
neuron firing differentially regulates tonic and phasic dopamine transmission. Nature 
neuroscience 6: 968–73. 
Gan JO, Walton ME, Phillips PEM (2010). Dissociable cost and benefit encoding of future 
rewards by mesolimbic dopamine. Nature neuroscience 13: 25–7. 
Grace AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine 
system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41: 
1–24. 
Guitart-Masip M, Beierholm U, Dolan R, Duzel E, Dayan P (2011). Vigor in the Face of 
Fluctuating Rates of Reward: An Experimental Examination. Journal of Cognitive 
Neuroscience 23: 1–6. 
Guitart-Masip M, Chowdhury R, Sharot T, Dayan P, Duzel E, Dolan RJ (2012a). Action controls 
dopaminergic enhancement of reward representations. Proceedings of the National 
Academy of Sciences of the United States of America 109: 7511–6. 
Guitart-Masip M, Huys QJM, Fuentemilla L, Dayan P, Duzel E, Dolan RJ (2012b). Go and no-
go learning in reward and punishment: Interactions between affect and effect. 
NeuroImage 62: 154–66. 
Hajós M, Gartside SE, Sharp T (1995). Inhibition of median and dorsal raphe neurones 
following administration of the selective serotonin reuptake inhibitor paroxetine. 
Naunyn-Schmiedeberg’s archives of pharmacology 351: 624–9. 
Huys QJM, Dayan P (2009). A Bayesian formulation of behavioral control. Cognition 1–
15doi:10.1016/j.cognition.2009.01.008. 
 17
Jacobs E, D’Esposito M (2011). Estrogen shapes dopamine-dependent cognitive processes: 
implications for women’s health. The Journal of Neuroscience 31: 5286–93. 
Knutson B, Adams CM, Fong GW, Hommer D (2001). Anticipation of increasing monetary 
reward selectively recruits nucleus accumbens. Journal of Neuroscience 21: RC159. 
Knutson B, Westdorp A, Kaiser E, Hommer D (2000). FMRI visualization of brain activity 
during a monetary incentive delay task. Neuroimage 12: 20–27. 
Lex A, Hauber W (2008). Dopamine D1 and D2 receptors in the nucleus accumbens core and 
shell mediate Pavlovian-instrumental transfer. Learning & memory (Cold Spring Harbor, 
NY) 15: 483–91. 
Mazzoni P, Hristova A, Krakauer JW (2007). Why don’t we move faster? Parkinson's disease, 
movement vigor, and implicit motivation. The Journal of neuroscience: the official 
journal of the Society for Neuroscience 27: 7105–16. 
McCleary RA (1961). Response specificity in the behavioral effects of limbic system lesions in 
the cat. Journal of Comparative and Physiological Psychology 54: 605–613. 
Mingote S, Weber SM, Ishiwari K, Correa M, Salamone JD (2005). Ratio and time 
requirements on operant schedules: effort-related effects of nucleus accumbens 
dopamine depletions. The European journal of neuroscience 21: 1749–57. 
Miyazaki K, Miyazaki KW, Doya K (2012). The role of serotonin in the regulation of patience 
and impulsivity. Molecular neurobiology 45: 213–24. 
Niv Y, Daw ND, Joel D, Dayan P (2007). Tonic dopamine: opportunity costs and the control of 
response vigor. Psychopharmacology 191: 507–20. 
Ossewaarde L, Wingen GA van, Kooijman SC, Bäckström T, Fernández G, Hermans EJ (2011). 
Changes in functioning of mesolimbic incentive processing circuits during the 
premenstrual phase. Social cognitive and affective neuroscience 6: 612–20. 
Ostlund SB, Wassum KM, Murphy NP, Balleine BW, Maidment NT (2011). Extracellular 
dopamine levels in striatal subregions track shifts in motivation and response cost 
during instrumental conditioning. The Journal of neuroscience: the official journal of 
the Society for Neuroscience 31: 200–7. 
Parkinson JA, Dalley JW, Cardinal RN, Bamford A, Fehnert B, Lachenal G, et al (2002). 
Nucleus accumbens dopamine depletion impairs both acquisition and performance of 
appetitive Pavlovian approach behaviour: implications for mesoaccumbens dopamine 
function. Behavioural brain research 137: 149–63. 
Salamone JD, Correa M (2002). Motivational views of reinforcement: implications for 
understanding the behavioral functions of nucleus accumbens dopamine. Behavioural 
brain research 137: 3–25. 
Salamone JD, Correa M (2012). The Mysterious Motivational Functions of Mesolimbic 
Dopamine. Neuron 76: 470–485. 
 18
Salamone JD, Steinpreis RE, McCullough LD, Smith P, Grebel D, Mahan K (1991). Haloperidol 
and nucleus accumbens dopamine depletion suppress lever pressing for food but 
increase free food consumption in a novel food choice procedure. 
Psychopharmacology 104: 515–21. 
Salamone JD, Wisniecki A, Carlson BB, Correa M (2001). Nucleus accumbens dopamine 
depletions make animals highly sensitive to high fixed ratio requirements but do not 
impair primary food reinforcement. Neuroscience 105: 863–70. 
Satoh T, Nakai S, Sato T (2003). Correlated coding of motivation and outcome of decision by 
dopamine neurons. Journal of Neuroscience 23: 9913–9923. 
Schultz W, Dayan P, Montague PR (1997). A neural substrate of prediction and reward. 
Science 275: 1593. 
Segovia KN, Correa M, Salamone JD (2011). Slow phasic changes in nucleus accumbens 
dopamine release during fixed ratio acquisition: a microdialysis study. Neuroscience 
196: 178–88. 
Selvaraj S, Turkheimer F, Rosso L, Faulkner P, Mouchlianitis E, Roiser JP, et al (2012). 
Measuring endogenous changes in serotonergic neurotransmission in humans: a 
[(11)C]CUMI-101 PET challenge study. Molecular psychiatry 17: 1254–60. 
Sokolowski JD, Conlan AN, Salamone JD (1998). A microdialysis study of nucleus accumbens 
core and shell dopamine during operant responding in the rat. Neuroscience 86: 1001–
9. 
Sokolowski JD, Salamone JD (1994). Effects of dopamine depletions in the medial prefrontal 
cortex on DRL performance and motor activity in the rat. Brain Research 642: 20–28. 
Soubrié P (1986). Reconciling the role of central serotonin neurons in human and animal 
behavior. Behavioral and Brain Sciences 9: 319–364. 
Talmi D, Seymour B, Dayan P, Dolan RJ (2008). Human pavlovian-instrumental transfer. The 
Journal of neuroscience: the official journal of the Society for Neuroscience 28: 360–8. 
Taylor JR, Robbins TW (1986). 6-Hydroxydopamine lesions of the nucleus accumbens, but 
not of the caudate nucleus, attenuate enhanced responding with reward-related 
stimuli produced by intra-accumbens d-amphetamine. Psychopharmacology 90: 390–7. 
Ungerstedt U (1971). Adipsia and aphagia after 6-hydroxydopamine induced degeneration 
of the nigro-striatal dopamine system. Acta physiologica Scandinavica Supplementum 
367: 95–122. 
Westerink B, Kwint H, deVries J (1996). The pharmacology of mesolimbic dopamine neurons: 
a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens 
of the rat brain. J Neurosci 16: 2605–2611. 
Winkel J, Maanen L van, Ratcliff R, Schaaf ME van der, Schouwenburg MR van, Cools R, et al 
(2012). Bromocriptine does not alter speed-accuracy tradeoff. Frontiers in neuroscience 
6: 126. 
 19
Wittmann BC, Schott BH, Guderian S, Frey JU, Heinze H-J, Düzel E (2005). Reward-related 
FMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-
dependent long-term memory formation. Neuron 45: 459–67. 
 
 
 
FIGURE LEGENDS 
 
Figure 1  
Structure of one trial of the behavioral task. Subjects are shown their potential reward, 
followed by an odd-one-out task to be completed within 500 msec (400 msec for 20% of 
trials). After a further 500 msec, they were shown their received reward. (B) The induced 
fluctuation in available reward (blue) and averaged reward (for learning rate ߙ ൌ 0.012 in 
red, the fixed value used in Guitart-Masip et al 2011, and ߙ ൌ 0.113 in green, the mean 
value across subjects found in the current analysis) varying over time. 
 
Figure 2 
ߚ values for data sets Dorig (blue; Guitart-Masip et al. 11), and Dtired (red), estimated through 
the expectation maximization algorithm. Error bars are standard errors and ‘*’ indicates 
significant difference in means at p<0.05 based on a 2-sample t-test. 
 
Figure 3 
ߚ values for subjects given placebo (blue), L-Dopa (red) and citalopram (green) estimated 
through expectation maximization algorithm. Error bars are standard errors and ‘*’ indicates 
significant difference in means at p<0.05 based on a 2-sample t-test. 
 
Figure 4 
Beta values for average reward rate regressor across conditions and experiments. Error bars 
are standard errors and ‘*’ indicates significant difference in means at p<0.05 based on a 2-
sample t-test. 
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